Chemokines are important mediators of the immune response to pathogens, but can also promote chronic inflammatory states. Chemokine receptor 6 (CCR6) is found on immature DC and effector/memory T cells, and binds a single ligand, CCL20, with high affinity. Here, we investigated the role of CCL20 and CCR6 in a pulmonary viral infection caused by RSV, a ubiquitous virus that can cause severe pulmonary complications. Neutralization of CCL20 during RSV infection significantly reduced lung pathology and favored a Th1 effector response. CCR6-deficient animals recapitulated this phenotype, and additionally showed enhanced viral clearance when compared with WT mice. No differences were observed in migration of T cells to the lungs of CCR6 À/À animals; however, a significant reduction was observed in numbers of conventional DC (cDC), but not plasmacytoid DC, in CCR6 À/À mice. A pathogenic phenotype could be reconstituted in CCR6 À/À mice by supplying cDC into the airway, indicating that mere number of cDC dictates the adverse response. Our data suggest that blockade of the CCL20/CCR6 pathway provides an environment whereby the attenuated recruitment of cDC alters the balance of innate immune cells and mediates the efficient antiviral response to RSV.Key words: Chemokines . DC . Mucosal immunity
IntroductionRSV is a pervasive virus that is the most common cause of hospitalization in children under the age of 2 [1]. RSV can also adversely affect the elderly and immunocompromised individuals, causing severe lower respiratory tract infection [2]. Although both Th1 and Th2 effector responses may be generated, Th2 immunity is responsible for RSV-associated pathology, including airway damage and mucus hypersecretion [3]. RSV represents a recurrent problem throughout life because immunologic memory never fully develops [4]. Furthermore, studies have demonstrated a correlation between early exposure to RSV and the later development of asthma [5,6]. No vaccine currently exists, and early attempts to develop a vaccine proved detrimental, as individuals inoculated with a formalin-inactivated form of virus demonstrated enhanced pulmonary eosinophilia and Th2 responses [7]. Clearly, further investigation is needed to clarify the fine balance between immune protection and pathology during RSV infection.Chemokines are key mediators of leukocyte recruitment during pathogenic insult, and also play a prominent role in homeostasis [8]. Most chemokines are promiscuous in that they can bind multiple receptors. CC chemokine receptor 6 (CCR6) is unique in the latter regard in that it binds a single chemokine, CCL20 [9]. CCL20 is a homeostatic chemokine, with a prominent role in organizing lymphoid tissue in the gut [10], but is also upregulated upon pro-inflammatory stimulation [11]. This dual function of CCL20 is evident in the cells expressing its corresponding receptor, CCR6, and contributes to a role for these cells in various immune settings.CCR6 is found on immature DC, B cells, effector/memory T cells and T regulatory cells [12][13][14][...